J1/174/2026 – PIRTOBRUTINIB 100 MG COMP - AUE 202503716
About This Opportunity
TranslatedThe tender J1/174/2026 pertains to the procurement of PIRTOBRUTINIB 100 MG COMP, identified by the reference AUE 202503716. This pharmaceutical product is intended for use in specific medical treatments, and the tender aims to secure a reliable supply of this medication. Key requirements for bidders may include compliance with regulatory standards for pharmaceutical products, proof of manufacturing capabilities, and adherence to quality assurance protocols. Additionally, bidders should demonstrate their ability to meet delivery timelines and provide adequate documentation regarding the product's efficacy and safety. The procurement is likely to be conducted within a public health framework, emphasizing the importance of accessibility and affordability of essential medications. Interested parties are encouraged to review the tender documents thoroughly to understand all specifications and submission guidelines. The location of the procurement process is not explicitly stated in the provided information, but it is typically associated with public health institutions or government agencies responsible for healthcare procurement. This tender represents an opportunity for pharmaceutical companies to contribute to the healthcare sector by providing essential medications that support patient care.
This is a supplies contract in the health and medical services, information and communication technology and finance and banking sectors, with a focus on Pharmaceuticals and Insurance. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 101,631.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender J1/174/2026 pertains to the procurement of Pirtobrutinib 100 mg capsules, as identified by the reference AUE 202503716. This tender is issued within the framework of public health procurement in Portugal, reflecting the government's commitment to ensuring the availability of essential medications for patients requiring advanced therapeutic options.
Pirtobrutinib is a novel medication utilized primarily in the treatment of certain hematological malignancies, notably in patients with chronic lymphocytic leukemia (CLL) and other related conditions. The contracting authority seeks suppliers capable of providing this pharmaceutical product in compliance with stringent regulatory standards.
Typical requirements for such a tender may include the submission of evidence demonstrating the supplier's capability to deliver the required product, including documentation of Good Manufacturing Practices (GMP), quality assurance certifications, and product stability data. Additionally, suppliers may need to provide details regarding their distribution capabilities, pricing structures, and commitment to timely delivery to ensure that healthcare providers can access this critical treatment without interruption.
Participants in this tender must adhere to applicable legislation governing public contracts in Portugal, ensuring transparency and fairness throughout the procurement process. Interested parties are encouraged to review the tender documents in detail and prepare their submissions accordingly, as the successful bidder will play a vital role in enhancing patient care through the provision of this important medication. This opportunity is significant for pharmaceutical companies looking to engage in public health initiatives within the Portuguese market.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 8 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde da Região de Leiria, E. P. E.
Unidade Local de Saúde da Região de Leiria, E. P. E. has issued 578 procurement notices on BidsFactory, including 1 currently open and 553 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LILLY PORTUGAL - PRODUTOS FARMACEUTICOS. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde da Região de Leiria, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €101,631. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.